Entering text into the input field will update the search result below

Novartis' Entresto (LCZ696) cleared in Switzerland

Sep. 18, 2015 7:32 AM ETNovartis AG (NVS) StockNVSBy: Douglas W. House, SA News Editor
  • Swissmedic clears Novartis' (NYSE:NVS) Entresto (sacubitril/valsartan), previously LCZ696, to reduce the risk of cardiovascular mortality and morbidity in patients with heart failure with reduce ejection fraction. About 150K people in Switzerland live with heart failure.
  • The FDA approved Entresto in July.

Recommended For You

More Trending News

About NVS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
NVS--
Novartis AG